Late Phase Market Overview and Outlook (2010)
$6,800.00 – $10,200.00
Related products
-
Select options This product has multiple variants. The options may be chosen on the product page
Improving Patient Recruitment in Biosimilar Trials
$3,260.00 – $6,520.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Post-marketing Safety Market Overview and Outlook
$4,900.00 – $7,350.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Optimizing Feasibility in Clinical Trials
$2,460.00 – $4,920.00 -
Select options This product has multiple variants. The options may be chosen on the product page
The Phase I Market Overview and Outlook
$4,900.00 – $7,350.00